Burns C. Blaxall

Nonsteroidal Anti-Inflammatory Drugs and Hypertension.

Correlation between intrinsic mRNA stability and the affinity of AUF1 (hnRNP D) and HuR for A+U-rich mRNAs.

Differential gene expression and genomic patient stratification following left ventricular assist device support.

Differential myocardial gene expression in the development and rescue of murine heart failure.

Angiotensin II: a devious activator of mineralocorticoid receptor-dependent gene expression.

Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: implication in heart failure.

A positive feedback loop of phosphodiesterase 3 (PDE3) and inducible cAMP early repressor (ICER) leads to cardiomyocyte apoptosis.

Nuclear RNA foci in the heart in myotonic dystrophy.

Phospholipase C epsilon modulates beta-adrenergic receptor-dependent cardiac contraction and inhibits cardiac hypertrophy.

Tissue factor is induced in a rodent model of severe pulmonary hypertension characterized by neointimal lesions typical of human disease.

Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium.

The future of endothelin-receptor antagonism as treatment for systemic hypertension.

Inhibiting p90 ribosomal S6 kinase prevents (Na+)-H+ exchanger-mediated cardiac ischemia-reperfusion injury.

Lymphocyte levels of GRK2 (betaARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved beta-adrenergic signaling after mechanical unloading.

CXCR4 modulates contractility in adult cardiac myocytes.

Epac-mediated activation of phospholipase C(epsilon) plays a critical role in beta-adrenergic receptor-dependent enhancement of Ca2+ mobilization in cardiac myocytes.

Activation of extracellular signal-regulated kinase 5 reduces cardiac apoptosis and dysfunction via inhibition of a phosphodiesterase 3A/inducible cAMP early repressor feedback loop.

A novel role for the glucocorticoid receptor in the regulation of monocyte chemoattractant protein-1 mRNA stability.

Gene expression profile of the recovering human heart.

Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension.

EPAC regulation of cardiac EC coupling.

Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy.

Identification of Nogo as a novel indicator of heart failure.

Enhanced calcium cycling and contractile function in transgenic hearts expressing constitutively active G alpha o* protein.

Epac and phospholipase Cepsilon regulate Ca2+ release in the heart by activation of protein kinase Cepsilon and calcium-calmodulin kinase II.

Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy.

Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.

Small molecule disruption of G beta gamma signaling inhibits the progression of heart failure.

Protein kinase Cδ mediates MCP-1 mRNA stabilization in vascular smooth muscle cells.

Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury.

Cardiovascular therapeutic discovery.

Nebulette mutations in cardiac remodeling: big effects from a small mechanosensor.

Taking the heart failure battle inside the cell: small molecule targeting of Gβγ subunits.

Cyclophilin A promotes cardiac hypertrophy in apolipoprotein E-deficient mice.

Mammalian enabled (Mena) is a critical regulator of cardiac function.

G protein coupled receptor kinase 2 interacting protein 1 (GIT1) is a novel regulator of mitochondrial biogenesis in heart.

G protein coupled receptor kinases as therapeutic targets in cardiovascular disease.

S100A1: Another Step Toward Therapeutic Development for Heart Failure.

New approaches in small animal echocardiography: imaging the sounds of silence.

PKC-ing is believing: targeting protein kinase C in heart failure.